Change to FIT increased CRC screening rates: Evaluation of a US screening outreach program

American Journal of Managed Care

Volumn 18, Issue 10, 2012, Pages 588-595

  Liles, Elizabeth G ^a   Perrin, Nancy ^a   Rosales, Ana Gabriela ^a   Feldstein, Adrianne C ^a,b   Smith, David H ^a   Mosen, David M ^a   Schneider, Jennifer L ^a  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b Northwest Permanente   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COLORECTAL CANCER; EVALUATION; FECAL IMMUNOCHEMICAL TEST; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; IMMUNOCHEMISTRY; INTEGRATED HEALTH CARE SYSTEM; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING TEST; CHEMISTRY; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FECES; MALE; MIDDLE AGED; PROCEDURES; REMINDER SYSTEM; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FECES; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MIDDLE AGED; NORTHWESTERN UNITED STATES; REMINDER SYSTEMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84869238119     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin. 2008;58(3):130-160. (Pubitemid 351830299)
2. American Cancer Society. Colorectal Cancer Facts and Figures Special Edition 2005. Atlanta, GA: American Cancer Society; 2005.
3. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544-573.
4. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occultblood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-1607. (Pubitemid 32162983)
5. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg. 2008;95(8):1029-1036.
6. Kronborg O, Jorgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol. 2004;39(9):846-851. (Pubitemid 39215455)
7. Scholefield JH, Moss S, Sufi F, Mangham CM, Hardcastle JD. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut. 2002;50(6):840-844. (Pubitemid 34539047)
8. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev. 2007;24(1):CD001216.
9. Faivre J, Dancourt V, Lejeune C, et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology. 2004;126(7):1674-1680. (Pubitemid 38736331)
10. DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening. J Gen Intern Med. 2008;23(2):169-174.
11. Almog R, Ezra G, Lavi I, Rennert G, Hagoel L. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening. Eur J Cancer Prev. 2008;17(5):430-437.
12. Powell AA, Burgess DJ, Vernon SW, et al. Colorectal cancer screening mode preferences among US veterans. Prev Med. 2009;49(5):442-448.
13. Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health. 2000;25(3):263-278. (Pubitemid 30387652)
14. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10(3):117-122. (Pubitemid 38296846)
15. Federici A, Giorgi Rossi P, Borgia P, Bartolozzi F, Farchi S, Gausticchi G. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen. 2005;12(2):83-88. (Pubitemid 40835139)
16. Fenton JJ, Elmore JG, Buist DS, Reid RJ, Tancredi DJ, Baldwin LM. Longitudinal adherence with fecal occult blood test screening in community practice. Ann Fam Med. 2010;8(5):397-401.
17. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82-90. (Pubitemid 351899018)
18. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer. 2009;100(7):1103-1110.
19. Hoffman RM, Steel S, Yee EF, Massie L, Schrader RM, Murata GH. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial. Prev Med. 2010;50(5-6):297-299.
20. Burch JA, Soares-Weiser K, St John DJ, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen. 2007;14(3):132-137. (Pubitemid 47511122)
21. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med. 2004;351(26):2704-2714. (Pubitemid 39665324)
22. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol. 2010;105(9):2017-2025.
23. Sohn DK, Jeong SY, Choi HS, et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Res Treat. 2005;37(1):20-23.
24. Nakama H, Yamamoto M, Kamijo N, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepatogastroenterology. 1999;46(25):228-231. (Pubitemid 29154752)
25. Morikawa T, Kato J, Yamaji Y, et al. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas. Am J Gastroenterol. 2007;102(10):2259-2264. (Pubitemid 47493843)
26. Cheng TI, Wong JM, Hong CF, et al. Colorectal cancer screening in asymptomaic adults: comparison of colonoscopy, sigmoidoscopy and fecal occult blood tests. J Formos Med Assoc. 2002;101(10):685-690.
27. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007;146(4):244.
28. US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627-637.
29. Freeborn DK, Pope C. Promise and Performance in Managed Care: The Prepaid Group Practice Model. Baltimore, MD: Johns Hopkins University Press; 1994.
30. Mosen DM, Feldstein AC, Perrin N, et al. Automated telephone calls improved completion of fecal occult blood testing. Med Care. 2010;48(7):604-610.
31. Costanza ME, Luckmann R, Stoddard AM, et al. Applying a stage model of behavior change to colon cancer screening. Prev Med. 2005;41(3-4):707-719. (Pubitemid 41400034)
32. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence to screening colonoscopy. J Gen Intern Med. 2005;20(11):989-995. (Pubitemid 41726651)
33. Myers RE, Sifri R, Hyslop T, et al. A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer. 2007;110(9):2083-2091. (Pubitemid 350036870)
34. Myers RE, Hyslop T, Sifri R, et al. Tailored navigation in colorectal cancer screening. Med Care. 2008;46(9 suppl 1):S123-S131.
35. McCaul KD, Goetz PW. Health Behavior Constructs: Theory, Measurement & Research: The Penn State Worry Questionnaire (PSWQ). Bethesda, MD: National Cancer Institute; 2008.
36. Lafata JE, Divine G, Moon C, Williams LK. Patient-physician colorectal cancer screening discussions and screening use. Am J Prev Med. 2006;31(3):202-209. (Pubitemid 44176308)
37. Agency for Healthcare Research and Quality (AHRQ). Consumer Assessment of Healthcare Providers and Systems (CAHPS). http://www.cahps.ahrq.gov/. Published 2011.
38. Glasgow RE, Magid DJ, Beck A, Ritzwoller D, Estabrooks PA. Practical clinical trials for translating research to practice: design and measurement recommendations. Med Care. 2005;43(6):551-557. (Pubitemid 40847291)
39. Lafata JE, Williams LK, Ben-Menachem T, Moon C, Divine G. Colorectal carcinoma screening procedure use among primary care patients. Cancer. 2005;104(7):1356-1361. (Pubitemid 41356150)
40. O'Malley AS, Forrest CB, Feng S, Mandelblatt J. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries. Arch Intern Med. 2005;165(18):2129-2135. (Pubitemid 41434589)
41. Klabunde CN, Schenck AP, Davis WW. Barriers to colorectal cancer screening among Medicare consumers. Am J Prev Med. 2006;30(4):313-319. (Pubitemid 43357920)
42. Farmer MM, Bastani R, Kwan L, Belman M, Ganz PA. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan. Cancer. 2008;112(6):1230-1238. (Pubitemid 351436333)
43. Guessous I, Dash C, Lapin P, Doroshenk M, Smith RA, Klabunde CN. Colorectal cancer screening barriers and facilitators in older persons. Prev Med. 2010;50(1-2):3-10.
44. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007;167(3):258-264.
45. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ. Correlates of underutilization of colorectal cancer screening among US adults, age 50 years and older. Prev Med. 2003;36(1):85-91. (Pubitemid 36034673)
46. Cooper GS, Doug KT. Underuse of colorectal cancer screening in a cohort of Medicare beneficiaries. Cancer. 2008;112(2):293-299.
47. Etzioni DA, Ponce NA, Babey SH, et al. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey. Cancer. 2004;101(11):2523-2532. (Pubitemid 39532281)
48. Klabunde CN, Meissner HI, Wooten KG, Breen N, Singleton JA. Comparing colorectal cancer screening and immunization status in older americans. Am J Prev Med. 2007;33(1):1-8. (Pubitemid 46908867)
49. Morales LS, Rogowski J, Freedman VA, Wickstrom SL, Adams JL, Escarce JJ. Sociodemographic differences in use of preventive services by women enrolled in Medicare+Choice plans. Prev Med. 2004;39(4):738-745. (Pubitemid 39194736)
50. Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Med Care. 2008;46(9 suppl 1):S84-S90.
51. Shenson D, Bolen J, Adams M. Receipt of preventive services by elders based on composite measures, 1997-2004. Am J Prev Med. 2007;32(1):11-81.
52. Shenson D, Bolen J, Adams M, Seeff L, Blackman D. Are older adults up-to-date with cancer screening and vaccinations? Prev Chronic Dis. 2005;2(3):A04.
53. Elta GH. Women are different from men. Gastrointest Endosc. 2002;56(2):308-309.
54. Jimenez B, Palekar N, Schneider A. Issues related to colorectal cancer and colorectal cancer screening practices in women. Gastroenterol Clin North Am. 2011;40(2):415-426, ix.
55. Menees SB, Inadomi JM, Korsnes S, Elta GH. Women patients' preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc. 2005;62(2):219-223. (Pubitemid 41021545)
56. Varadarajulu S, Petruff C, Ramsey WH. Patient preferences for gender of endoscopists. Gastrointest Endosc. 2002;56(2):170-173.
57. Zapatier JA, Kumar AR, Perez A, Guevara R, Schneider A. Preferences for ethnicity and sex of endoscopists in a Hispanic population in the United States. Gastrointest Endosc. 2011;73(1):89-97, 97.e1-4.
58. Schneider A, Kanagarajan N, Anjelly D, Reynolds JC, Ahmad A. Importance of gender, socioeconomic status, and history of abuse on patient preference for endoscopist. Am J Gastroenterol. 2009;104(2):340-348.
59. Lee SY, Yu SK, Kim JH, et al. Link between a preference for women colonoscopists and social status in Korean women. Gastrointest Endosc. 2008;67(2):273-277.
60. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult US population. Cancer. 2004;100(10):2093-2103. (Pubitemid 38580326)
61. Centers for Disease Control and Prevention (CDC). Vital signs: colorectal cancer screening among adults aged 50-75 years-United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;59(26):808-812.
62. Swan J, Breen N, Graubard BI, et al. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer. 2010;116(20):4872-4881.
63. Brawarsky P, Brooks DR, Mucci LA. Correlates of colorectal cancer testing in Massachusetts men and women. Prev Med. 2003;36(6):659-668. (Pubitemid 36555545)
64. Stockwell DH, Woo P, Jacobson BC, et al. Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol. 2003;98(8):1875-1880. (Pubitemid 36959173)
65. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol.2003;98(9): 2082-2091. (Pubitemid 37185810)
66. Doubeni CA, Laiyemo AO, Young AC, et al. Primary care, economic barriers to health care, and use of colorectal cancer screening tests among Medicare enrollees over time. Ann Fam Med. 2010;8(4):299-307.